Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Michael Rosenblatt > Profile

Michael Rosenblatt

Affiliations

  • at Azenta Inc. (AZTA), 2024-02-13
  • Director at Axcella Health Inc. (AXLA), 2022-05-23
  • Director at Rubius Therapeutics Inc. (RUBY), 2022-05-13
  • Exec V-P & Chief Med Officer at Merck & Co. Inc. (MRK), 2016-05-12
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
BRKS $114.13 2,831 $323,102.03 5,051 2021-11-12 Filing
BRKS $90.00 1,760 $158,400.00 7,882 2021-05-13 Filing